FcRn and Myasthenia Gravis
Released On
November 7, 2024
Expires On
November 6, 2025
Media Type
Internet
Completion Time
30 minutes
Specialty
Neurology, Ophthalmology
Topics
Myasthenia Gravis, Movement Disorders, Autoimmune Disease
Jointly provided by American Academy of CME and CheckRare CE.
This activity is supported by an independent educational grant from Argenx.
Credit Available
- Physicians - maximum of 0.50 AMA PRA Category 1 Credits™
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This activity has been designed to meet the educational needs of physicians specializing in neurology and ophthalmology who may be involved in the diagnosis and care of individuals with MG. Other healthcare providers, including neurology NPs and PAs, may also participate.
Program Overview
This 30-minute CME program discusses how the FcRn system can impact myasthenia gravis and how FcRn antagonists can be used to treat this rare condition.
Learning Objectives
After participating in the activity, learners should be better able to:
- Describe the role of FcRn in MG.
- Describe the efficacy of the treatment options for MG that target FcRn.
- Compare the safety of the treatment options for MG that target FcRn.
Faculty
Richard J. Nowak, MD, MS
Director, Program in Clinical & Translational Neuromuscular Research (CTNR)
Director, Yale Myasthenia Gravis Clinic
Associate Professor of Neurology
Division of Neuromuscular Medicine
Department of Neurology
Yale School of Medicine
New Haven, CT
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Academy of CME, Inc., designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts Of Interest
American Academy of CME and CheckRare CE staff, as well as planning and review committees, have no financial interests to disclose.
Faculty Educators
Dr. Nowak discloses the following relevant financial relationships with ineligible companies:
- Advisory Board/Consultant: Alexion (part of AstraZeneca), argenx, Amgen, Cour Pharmaceuticals, Immunovant, Janssen, UCB
- Grant/Research Support: Alexion (part of AstraZeneca), argenx, Amgen, Cour Pharmaceuticals, Immunovant, Janssen, UCB
Instructions for Participation and Credit
TThere are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the post-test (achieving a passing score of 70%) and the evaluation form.
Certificates will be immediately available for download.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
American Academy of CME, Inc. requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. This activity will review off-label or investigational information.
Disclaimer
The opinions expressed in this educational activity are those of the faculty, and do not represent those of the American Academy of CME or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
Contact Information
For CME questions please contact: [email protected]